SUMMARY In a population and family study we We have reported population studies9 10 in which apparently normal subjects with no known family history of CAH had raised levels of 17 PO in response to ACTH stimulation. These were designated simply as type 2 responders because the relationship to the various forms of 21 OH deficiency was unknown. In some instances there was a concomitant excessive rise in progesterone (PO) levels and the response of 17 PO to ACTH was frequently greater than that seen in obligate carriers of CAH. Early in these studies we encountered some women with type 2 response who were infertile. This led us to undertake a study of the frequency of this variant which we then showed was not related to any specific form of female infertility. It)
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We were able to take advantage of this extensive clinical study to 21 hydroxylase activity in these subjects. Since there was no significant difference between the normal volunteer and gynaecology patient groups for the 60 minute increment levels, data from these groups were pooled. The limits which define apparently normal 21 OH activity were determined by plotting the 60 minute increment levels for each steroid on probability paper (figs 1 and 2). This revealed a polymodal distribution for both steroids suggesting the existence of different populations with differing 21 OH activities. The normal limits were taken at the first point of inflexion (-*-), these being 7-0 nmol/l for 17 PO and 5-0 nmol/l for PO. For 17 PO , 22 of 285 subjects tested (7 7%) had increment values above 7-0 nmol/l (from now on designated the type 2 response). These included two male volunteers, five female volunteers, and 15 gynaecological patients, representing 9-1%, 9-7%, and 9-5%, respectively of each group tested. A total of 2-5% of subjects tested for PO (two male volunteers, two female volunteers, three female patients) were found to have raised increment values of this steroid. Table 2 shows the steroid data for 274 subjects tested for both steroids and according to 17 
